The transcribed pseudogene RPSAP52 enhances the oncofetal HMGA2-IGF2BP2-RAS axis through LIN28B-dependent and independent let-7 inhibition
| Main Author: | |
|---|---|
| Publication Date: | 2019 |
| Other Authors: | , , , , , , , , , , , , , , , , , |
| Format: | Article |
| Language: | eng |
| Source: | Repositório Institucional da FIOCRUZ (ARCA) |
| DOI: | 10.1038/s41467-019-11910-6 |
| Download full: | https://arca.fiocruz.br/handle/icict/37085 |
Summary: | Bellvitge Biomedical Research Institute. L’Hospitalet de Llobregat. Cancer Epigenetics and Biology Program. Barcelona, Catalonia, Spain. |
| id |
CRUZ_6fa057a8b1f87ae6fc493dcec728741c |
|---|---|
| oai_identifier_str |
oai:arca.fiocruz.br:icict/37085 |
| network_acronym_str |
CRUZ |
| network_name_str |
Repositório Institucional da FIOCRUZ (ARCA) |
| repository_id_str |
2135 |
| spelling |
Mateos, Cristina OliveiraCastillo, Anaís SánchezSoler, MartaGuardia, Aida ObiolsPiñeyro, DavidSastre, Raquel BoqueCervantes, Maria E. CallejaMoura, Manuel Castro deCardús, Anna MartínezRubio, TeresaPelletier, JoffreyIniesta, Maria MartínezMartín, David HerreroTirado, Oscar M.Gentilella, AntonioVillanueva, AlbertoEsteller, ManelVallve, Maria de Lourdes FarreGuil, Sonia2019-11-14T18:43:18Z2019-11-14T18:43:18Z2019MATEOS, Cristina Oliveira et al. The transcribed pseudogene RPSAP52 enhances the oncofetal HMGA2-IGF2BP2-RAS axis through LIN28B-dependent and independent let-7 inhibition. Nature Communications, v. 10, p. 1-18, 2019.2041-1723https://arca.fiocruz.br/handle/icict/3708510.1038/s41467-019-11910-6engNature ResearchPseudogenesTumoresProteína HMGA2PrognósticoPseudogenesNeoplasmsHMGA2 ProteinPrognosisThe transcribed pseudogene RPSAP52 enhances the oncofetal HMGA2-IGF2BP2-RAS axis through LIN28B-dependent and independent let-7 inhibitioninfo:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/articleBellvitge Biomedical Research Institute. L’Hospitalet de Llobregat. Cancer Epigenetics and Biology Program. Barcelona, Catalonia, Spain.Bellvitge Biomedical Research Institute. L’Hospitalet de Llobregat. Cancer Epigenetics and Biology Program. Barcelona, Catalonia, Spain / Carlos III Institute of Health. Centro de Investigación Biomédica en Red de Cáncer. Madrid, Spain.Bellvitge Biomedical Research Institute. L’Hospitalet de Llobregat. Cancer Epigenetics and Biology Program. Barcelona, Catalonia, Spain.Bellvitge Biomedical Research Institute. L’Hospitalet de Llobregat. Cancer Epigenetics and Biology Program. Barcelona, Catalonia, Spain.Bellvitge Biomedical Research Institute. L’Hospitalet de Llobregat. Cancer Epigenetics and Biology Program. Barcelona, Catalonia, Spain.Bellvitge Biomedical Research Institute. L’Hospitalet de Llobregat. Cancer Epigenetics and Biology Program. Barcelona, Catalonia, Spain / Cardiff School of Biosciences. Cardiff University. Wales, UK.Bellvitge Biomedical Research Institute. L’Hospitalet de Llobregat. Cancer Epigenetics and Biology Program. Barcelona, Catalonia, Spain.Bellvitge Biomedical Research Institute. L’Hospitalet de Llobregat. Cancer Epigenetics and Biology Program. Barcelona, Catalonia, Spain.Bellvitge Biomedical Research Institute. L’Hospitalet de Llobregat. Cancer Epigenetics and Biology Program. Barcelona, Catalonia, Spain.Bellvitge Biomedical Research Institute. L’Hospitalet de Llobregat. Laboratory of Cancer Metabolism. Barcelona, Catalonia, Spain.Bellvitge Biomedical Research Institute. L’Hospitalet de Llobregat. Laboratory of Cancer Metabolism. Barcelona, Catalonia, Spain.IDIBELLL’Hospitalet de Llobregat. Program Against Cancer Therapeutic Resistance. Barcelona, Catalonia, Spain.Bellvitge Biomedical Research Institute. L’Hospitalet de Llobregat. Sarcoma Research Group. Barcelona, Catalonia, Spain.Carlos III Institute of Health. Centro de Investigación Biomédica en Red de Cáncer. Madrid, Spain / Bellvitge Biomedical Research Institute. L’Hospitalet de Llobregat. Sarcoma Research Group. Barcelona, Catalonia, Spain.Bellvitge Biomedical Research Institute. L’Hospitalet de Llobregat. Laboratory of Cancer Metabolism. Barcelona, Catalonia, Spain / University of Barcelona. Faculty of Pharmacy. Department of Biochemistry and Physiology. Barcelona, Catalonia, Spain.IDIBELLL’Hospitalet de Llobregat. Program Against Cancer Therapeutic Resistance.Barcelona, Catalonia, Spain.Bellvitge Biomedical Research Institute. L’Hospitalet de Llobregat. Cancer Epigenetics and Biology Program. Barcelona, Catalonia, Spain / Carlos III Institute of Health. Centro de Investigación Biomédica en Red de Cáncer. Madrid, Spain / University of Barcelona. School of Medicine and Health Sciences. Physiological Sciences Department. Barcelona, Catalonia, Spain / Institució Catalana de Recerca i Estudis Avançats. Barcelona, Catalonia, Spain / Josep Carreras Leukaemia Research Institute Badalona. Barcelona, Catalonia, Spain.IDIBELL,L’Hospitalet de Llobregat. Program Against Cancer Therapeutic Resistance.Barcelona, Catalonia, Spain / Fundação Oswaldo Cruz. Instituto Gonçalo Moniz. Laboratório de Patologia Experimental. Salvador, BA, Brasil.Bellvitge Biomedical Research Institute. L’Hospitalet de Llobregat. Cancer Epigenetics and Biology Program. Barcelona, Catalonia, Spain / Josep Carreras Leukaemia Research Institute. Badalona, Barcelona, Catalonia, Spain.One largely unknown question in cell biology is the discrimination between inconsequential and functional transcriptional events with relevant regulatory functions. Here, we find that the oncofetal HMGA2 gene is aberrantly reexpressed in many tumor types together with its antisense transcribed pseudogene RPSAP52. RPSAP52 is abundantly present in the cytoplasm, where it interacts with the RNA binding protein IGF2BP2/IMP2, facilitating its binding to mRNA targets, promoting their translation by mediating their recruitment on polysomes and enhancing proliferative and self-renewal pathways. Notably, downregulation of RPSAP52 impairs the balance between the oncogene LIN28B and the tumor suppressor let-7 family of miRNAs, inhibits cellular proliferation and migration in vitro and slows down tumor growth in vivo. In addition, high levels of RPSAP52 in patient samples associate with a worse prognosis in sarcomas. Overall, we reveal the roles of a transcribed pseudogene that may display properties of an oncofetal master regulator in human cancers.info:eu-repo/semantics/openAccessreponame:Repositório Institucional da FIOCRUZ (ARCA)instname:Fundação Oswaldo Cruz (FIOCRUZ)instacron:FIOCRUZLICENSElicense.txtlicense.txttext/plain; charset=utf-82991https://arca.fiocruz.br/bitstreams/85b9485f-c75a-43bf-a0e5-0ea33c2f5f35/download5a560609d32a3863062d77ff32785d58MD51falseAnonymousREADORIGINALOliveira, M. The_transcribed....pdfOliveira, M. The_transcribed....pdfapplication/pdf2639421https://arca.fiocruz.br/bitstreams/7045b9de-ba72-4c43-8c07-6cd524977210/download651f2a2ec223a67a3e7d3fac77d43034MD52trueAnonymousREADTEXTOliveira, M. The_transcribed....pdf.txtOliveira, M. The_transcribed....pdf.txtExtracted texttext/plain100460https://arca.fiocruz.br/bitstreams/17451c38-e55d-4be1-bdc8-15b04bb958ca/download24060365bc8c184f9048e78ed8eab513MD57falseAnonymousREADTHUMBNAILOliveira, M. The_transcribed....pdf.jpgOliveira, M. The_transcribed....pdf.jpgGenerated Thumbnailimage/jpeg5319https://arca.fiocruz.br/bitstreams/d3843a99-17aa-4bb6-881c-1f025184fd2e/download4719e5994c69ff5b1e8b6b5346a42077MD58falseAnonymousREADicict/370852025-07-29 20:40:55.778open.accessoai:arca.fiocruz.br:icict/37085https://arca.fiocruz.brRepositório InstitucionalPUBhttps://www.arca.fiocruz.br/oai/requestrepositorio.arca@fiocruz.bropendoar:21352025-07-29T23:40:55Repositório Institucional da FIOCRUZ (ARCA) - Fundação Oswaldo Cruz (FIOCRUZ)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 |
| dc.title.none.fl_str_mv |
The transcribed pseudogene RPSAP52 enhances the oncofetal HMGA2-IGF2BP2-RAS axis through LIN28B-dependent and independent let-7 inhibition |
| title |
The transcribed pseudogene RPSAP52 enhances the oncofetal HMGA2-IGF2BP2-RAS axis through LIN28B-dependent and independent let-7 inhibition |
| spellingShingle |
The transcribed pseudogene RPSAP52 enhances the oncofetal HMGA2-IGF2BP2-RAS axis through LIN28B-dependent and independent let-7 inhibition Mateos, Cristina Oliveira Pseudogenes Tumores Proteína HMGA2 Prognóstico Pseudogenes Neoplasms HMGA2 Protein Prognosis |
| title_short |
The transcribed pseudogene RPSAP52 enhances the oncofetal HMGA2-IGF2BP2-RAS axis through LIN28B-dependent and independent let-7 inhibition |
| title_full |
The transcribed pseudogene RPSAP52 enhances the oncofetal HMGA2-IGF2BP2-RAS axis through LIN28B-dependent and independent let-7 inhibition |
| title_fullStr |
The transcribed pseudogene RPSAP52 enhances the oncofetal HMGA2-IGF2BP2-RAS axis through LIN28B-dependent and independent let-7 inhibition |
| title_full_unstemmed |
The transcribed pseudogene RPSAP52 enhances the oncofetal HMGA2-IGF2BP2-RAS axis through LIN28B-dependent and independent let-7 inhibition |
| title_sort |
The transcribed pseudogene RPSAP52 enhances the oncofetal HMGA2-IGF2BP2-RAS axis through LIN28B-dependent and independent let-7 inhibition |
| author |
Mateos, Cristina Oliveira |
| author_facet |
Mateos, Cristina Oliveira Castillo, Anaís Sánchez Soler, Marta Guardia, Aida Obiols Piñeyro, David Sastre, Raquel Boque Cervantes, Maria E. Calleja Moura, Manuel Castro de Cardús, Anna Martínez Rubio, Teresa Pelletier, Joffrey Iniesta, Maria Martínez Martín, David Herrero Tirado, Oscar M. Gentilella, Antonio Villanueva, Alberto Esteller, Manel Vallve, Maria de Lourdes Farre Guil, Sonia |
| author_role |
author |
| author2 |
Castillo, Anaís Sánchez Soler, Marta Guardia, Aida Obiols Piñeyro, David Sastre, Raquel Boque Cervantes, Maria E. Calleja Moura, Manuel Castro de Cardús, Anna Martínez Rubio, Teresa Pelletier, Joffrey Iniesta, Maria Martínez Martín, David Herrero Tirado, Oscar M. Gentilella, Antonio Villanueva, Alberto Esteller, Manel Vallve, Maria de Lourdes Farre Guil, Sonia |
| author2_role |
author author author author author author author author author author author author author author author author author author |
| dc.contributor.author.fl_str_mv |
Mateos, Cristina Oliveira Castillo, Anaís Sánchez Soler, Marta Guardia, Aida Obiols Piñeyro, David Sastre, Raquel Boque Cervantes, Maria E. Calleja Moura, Manuel Castro de Cardús, Anna Martínez Rubio, Teresa Pelletier, Joffrey Iniesta, Maria Martínez Martín, David Herrero Tirado, Oscar M. Gentilella, Antonio Villanueva, Alberto Esteller, Manel Vallve, Maria de Lourdes Farre Guil, Sonia |
| dc.subject.other.none.fl_str_mv |
Pseudogenes Tumores Proteína HMGA2 Prognóstico |
| topic |
Pseudogenes Tumores Proteína HMGA2 Prognóstico Pseudogenes Neoplasms HMGA2 Protein Prognosis |
| dc.subject.en.none.fl_str_mv |
Pseudogenes Neoplasms HMGA2 Protein Prognosis |
| description |
Bellvitge Biomedical Research Institute. L’Hospitalet de Llobregat. Cancer Epigenetics and Biology Program. Barcelona, Catalonia, Spain. |
| publishDate |
2019 |
| dc.date.accessioned.fl_str_mv |
2019-11-14T18:43:18Z |
| dc.date.available.fl_str_mv |
2019-11-14T18:43:18Z |
| dc.date.issued.fl_str_mv |
2019 |
| dc.type.status.fl_str_mv |
info:eu-repo/semantics/publishedVersion |
| dc.type.driver.fl_str_mv |
info:eu-repo/semantics/article |
| format |
article |
| status_str |
publishedVersion |
| dc.identifier.citation.fl_str_mv |
MATEOS, Cristina Oliveira et al. The transcribed pseudogene RPSAP52 enhances the oncofetal HMGA2-IGF2BP2-RAS axis through LIN28B-dependent and independent let-7 inhibition. Nature Communications, v. 10, p. 1-18, 2019. |
| dc.identifier.uri.fl_str_mv |
https://arca.fiocruz.br/handle/icict/37085 |
| dc.identifier.issn.none.fl_str_mv |
2041-1723 |
| dc.identifier.doi.none.fl_str_mv |
10.1038/s41467-019-11910-6 |
| identifier_str_mv |
MATEOS, Cristina Oliveira et al. The transcribed pseudogene RPSAP52 enhances the oncofetal HMGA2-IGF2BP2-RAS axis through LIN28B-dependent and independent let-7 inhibition. Nature Communications, v. 10, p. 1-18, 2019. 2041-1723 10.1038/s41467-019-11910-6 |
| url |
https://arca.fiocruz.br/handle/icict/37085 |
| dc.language.iso.fl_str_mv |
eng |
| language |
eng |
| dc.rights.driver.fl_str_mv |
info:eu-repo/semantics/openAccess |
| eu_rights_str_mv |
openAccess |
| dc.publisher.none.fl_str_mv |
Nature Research |
| publisher.none.fl_str_mv |
Nature Research |
| dc.source.none.fl_str_mv |
reponame:Repositório Institucional da FIOCRUZ (ARCA) instname:Fundação Oswaldo Cruz (FIOCRUZ) instacron:FIOCRUZ |
| instname_str |
Fundação Oswaldo Cruz (FIOCRUZ) |
| instacron_str |
FIOCRUZ |
| institution |
FIOCRUZ |
| reponame_str |
Repositório Institucional da FIOCRUZ (ARCA) |
| collection |
Repositório Institucional da FIOCRUZ (ARCA) |
| bitstream.url.fl_str_mv |
https://arca.fiocruz.br/bitstreams/85b9485f-c75a-43bf-a0e5-0ea33c2f5f35/download https://arca.fiocruz.br/bitstreams/7045b9de-ba72-4c43-8c07-6cd524977210/download https://arca.fiocruz.br/bitstreams/17451c38-e55d-4be1-bdc8-15b04bb958ca/download https://arca.fiocruz.br/bitstreams/d3843a99-17aa-4bb6-881c-1f025184fd2e/download |
| bitstream.checksum.fl_str_mv |
5a560609d32a3863062d77ff32785d58 651f2a2ec223a67a3e7d3fac77d43034 24060365bc8c184f9048e78ed8eab513 4719e5994c69ff5b1e8b6b5346a42077 |
| bitstream.checksumAlgorithm.fl_str_mv |
MD5 MD5 MD5 MD5 |
| repository.name.fl_str_mv |
Repositório Institucional da FIOCRUZ (ARCA) - Fundação Oswaldo Cruz (FIOCRUZ) |
| repository.mail.fl_str_mv |
repositorio.arca@fiocruz.br |
| _version_ |
1839715990673293312 |